Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Pharma giant Gilead Sciences again plays the villain in this story but there’s plenty of blame to go around.
NoiseFilter’s latest animated HIV series explains U=U, PrEP and PEP—with help from trans activist Milan Nicole Sherry.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Descovy may be a better option than Truvada for those at risk for kidney problems.
Long-acting injections given every two months could soon offer a new option for HIV pre-exposure prophylaxis.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
The Aliveness Project’s Thrive clinic in Minneapolis covers the cost of PrEP, lab tests and STI and HIV screenings.
Taking Truvada or Descovy to prevent HIV may be the first opportunity to encounter regular health care.
More HIV prevention misinformation is coming from the right.
According to a recent study, transgender women might benefit more than they think from the prevention pill.
Sometimes the older formulation of tenofovir is a better choice for HIV prevention.
Twice monthly injections for HIV prevention could be approved early next year.
Watch PACHA’s recent virtual meeting, which covered PrEP, the U.S. plan to end the HIV epidemic and new council members and cochairs
PrEP taken before and after sex, instead of daily dosing, has been found to be highly effective.
Little HIV prevention research has included pregnant women for fear of adverse birth outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.